A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo - Kenneth R. LaMontagne; Jeannene Butler; Virna B. Borowski; Angel R. Fuentes-Pesquera; Jonathan M. Blevitt; Shenlin Huang; Ronghua Li; Peter J. Connolly; Lee M. Greenberger (Angiogenesis, 2009)